PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.300
+0.010 (0.78%)
Apr 2, 2025, 4:00 PM EDT - Market closed

PharmaCyte Biotech Balance Sheet

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2015 - 2019
Cash & Equivalents
16.3850.1868.0485.42.20.89
Upgrade
Cash & Short-Term Investments
16.7650.1868.0485.42.20.89
Upgrade
Cash Growth
-72.63%-26.25%-20.33%3778.14%146.08%73.67%
Upgrade
Prepaid Expenses
0.210.260.110.090.070.14
Upgrade
Total Current Assets
16.9650.4468.1585.492.281.04
Upgrade
Long-Term Investments
18.63-1.571.571.571.57
Upgrade
Other Intangible Assets
1.551.553.553.553.553.55
Upgrade
Other Long-Term Assets
6.697.910.010.010.010.01
Upgrade
Total Assets
43.8359.973.2890.627.46.17
Upgrade
Accounts Payable
0.480.390.130.210.170.19
Upgrade
Accrued Expenses
0.710.740.460.50.50.7
Upgrade
Short-Term Debt
----0.050.11
Upgrade
Current Portion of Long-Term Debt
-----0.03
Upgrade
Other Current Liabilities
-0.46----
Upgrade
Total Current Liabilities
1.191.590.590.70.721.03
Upgrade
Long-Term Debt
-----0.05
Upgrade
Other Long-Term Liabilities
2.3812.97----
Upgrade
Total Liabilities
3.5814.560.590.70.721.08
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
181.43185.33202.23201.58114.11108.97
Upgrade
Retained Earnings
-96.72-115.63-115.96-111.65-107.41-103.86
Upgrade
Treasury Stock
-44.43-42.04-13.56---
Upgrade
Comprehensive Income & Other
-0.02-0.02-0.02-0.02-0.02-0.02
Upgrade
Total Common Equity
40.2527.6572.6989.926.685.09
Upgrade
Shareholders' Equity
40.2545.3572.6989.926.685.09
Upgrade
Total Liabilities & Equity
43.8359.973.2890.627.46.17
Upgrade
Total Debt
----0.050.19
Upgrade
Net Cash (Debt)
16.7650.1868.0485.42.150.71
Upgrade
Net Cash Growth
-72.63%-26.25%-20.33%3869.72%204.54%37.10%
Upgrade
Net Cash Per Share
2.185.243.495.501.490.78
Upgrade
Filing Date Shares Outstanding
6.867.718.7820.751.611.56
Upgrade
Total Common Shares Outstanding
6.98.0416.7920.721.591.09
Upgrade
Working Capital
15.7748.8567.5684.791.550.01
Upgrade
Book Value Per Share
5.833.444.334.344.204.66
Upgrade
Tangible Book Value
38.726.169.1486.373.131.54
Upgrade
Tangible Book Value Per Share
5.603.254.124.171.971.41
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q